Teva- Pharmaceutical Industries Ltd. ADR (NYSE:TEVA) traded at $17.09 at close of the session on Tuesday, June 24 and made an upward move of 0.71% on its previous day’s price.
Looking at the stock we see that its previous close was $16.97 and the beta (5Y monthly) reads 0.608 with the day’s price range being $16.9701 – $17.25. In terms of its 52-week price range, TEVA has a high of $22.80 and a low of $12.47. The company’s stock has gained about 0.89% over that past 30 days.
Teva- Pharmaceutical Industries Ltd. ADR has a market cap of $19.60 billion and is expected to release its quarterly earnings report on 2025-May-07.
On the other hand, looking at the outlook for the TEVA stock, short term indicators assign the stock an average of Hold, while medium term indicators assign it an average of Hold.
Based on estimates by 8 analysts, where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, 1 have rated the Teva- Pharmaceutical Industries Ltd. ADR (TEVA) stock as a Hold, while 6 rate it as a Buy. 0 analyst(s) rate it as overweight while 0 of them rated it as underweight, whereas 1 suggest the stock as a Sell. The stock has an overall rating of Buy and investors could take advantage and scoop up stock of the company.
Looking further, we note the current price level is -1.58% off its SMA20 and 4.25% from its 50-day simple moving average. The RSI (14) is pointing at 50.26 while the volatility over the past week is 0.73% and jumps to 2.68% over the past one month. The average price target for the stock over the next 12 months is $22, with the estimates having a low of $10 and a high of $28. These price ends are 41.49% and -63.84% off the current price level respectively, although investors could be excited at the prospect of a -28.73% if the TEVA share price touches on the median price of $22.
Coming back to Teva- Pharmaceutical Industries Ltd. ADR (NYSE:TEVA), we note that the average 3-month trading volume was 12.26 million, while that of the preceding 10-day period stands at 11.22 million. Current shares outstanding are 1.15 billion.
The insiders hold 0.01% of the company’s shares while institutions hold 62.86%. The data shows that short shares as of 2025-05-30, stood at 35.67 million at a short ratio of 2.61. This represents a 313.00 short interest in shares outstanding on 2025-05-30. Shares short rose in May from the previous month at 28.43 million. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock 0.18% up in year-to-date price movement.
